PulmonxCorp Total Liab vs Capital Stock Analysis

LUNG Stock

USD 8.07 0.31 3.70%

PulmonxCorp financial indicator trend analysis is much more than just breaking down PulmonxCorp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PulmonxCorp is a good investment. Please check the relationship between PulmonxCorp Total Liab and its Capital Stock accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in PulmonxCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in PulmonxCorp Stock please use our How to Invest in PulmonxCorp guide.

Total Liab vs Capital Stock

Total Liab vs Capital Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PulmonxCorp Total Liab account and Capital Stock. At this time, the significance of the direction appears to have no relationship.

The correlation between PulmonxCorp's Total Liab and Capital Stock is 0.07. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Capital Stock in the same time period over historical financial statements of PulmonxCorp, assuming nothing else is changed. The correlation between historical values of PulmonxCorp's Total Liab and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of PulmonxCorp are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Total Liab i.e., PulmonxCorp's Total Liab and Capital Stock go up and down completely randomly.

Correlation Coefficient

0.07

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Capital Stock

The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.

Most indicators from PulmonxCorp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PulmonxCorp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in PulmonxCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in PulmonxCorp Stock please use our How to Invest in PulmonxCorp guide.The PulmonxCorp's current Selling General Administrative is estimated to increase to about 93.9 M, while Tax Provision is projected to decrease to roughly 339.7 K.

PulmonxCorp fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Inventory	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Receivables	Other Assets	Other Current Assets	Intangible Assets	Short Long Term Debt Total	Other Current Liab	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total
Total Assets		0.77	0.77	0.76	-0.8	0.65	0.96	0.55	0.85	0.13	-0.16	1.0	0.58	0.88	0.91	0.6	0.38	0.95	0.04	-0.39	0.78	-0.76	0.93	-0.5	-0.95	0.86
Total Current Liabilities	0.77		0.47	0.55	-0.99	0.78	0.63	0.86	0.95	0.44	0.14	0.75	0.81	0.77	0.74	0.92	0.35	0.8	-0.03	-0.27	0.94	-0.82	0.88	-0.37	-0.64	0.93
Total Stockholder Equity	0.77	0.47		0.99	-0.48	0.09	0.79	0.21	0.67	-0.5	0.12	0.79	0.63	0.67	0.57	0.43	0.14	0.77	-0.49	-0.06	0.53	-0.41	0.65	-0.63	-0.79	0.64
Net Tangible Assets	0.76	0.55	0.99		-0.55	0.11	0.76	0.31	0.72	-0.46	0.23	0.77	0.73	0.68	0.55	0.53	0.1	0.76	-0.54	0.02	0.59	-0.44	0.66	-0.67	-0.76	0.69
Retained Earnings	-0.8	-0.99	-0.48	-0.55		-0.78	-0.66	-0.89	-0.95	-0.44	-0.08	-0.78	-0.79	-0.79	-0.73	-0.91	-0.38	-0.81	-0.01	0.24	-0.93	0.77	-0.87	0.42	0.67	-0.92
Accounts Payable	0.65	0.78	0.09	0.11	-0.78		0.53	0.67	0.69	0.78	-0.36	0.63	0.29	0.54	0.77	0.65	0.51	0.63	0.46	-0.61	0.73	-0.82	0.78	-0.04	-0.55	0.69
Cash	0.96	0.63	0.79	0.76	-0.66	0.53		0.44	0.72	0.04	-0.21	0.97	0.47	0.79	0.87	0.44	0.25	0.86	0.1	-0.39	0.59	-0.7	0.85	-0.59	-1.0	0.69
Long Term Debt	0.55	0.86	0.21	0.31	-0.89	0.67	0.44		0.78	0.57	0.14	0.53	0.69	0.57	0.49	0.83	0.1	0.53	0.18	-0.01	0.71	-0.57	0.6	-0.41	-0.44	0.68
Inventory	0.85	0.95	0.67	0.72	-0.95	0.69	0.72	0.78		0.22	0.06	0.83	0.8	0.76	0.77	0.9	0.33	0.89	-0.16	-0.23	0.93	-0.78	0.9	-0.43	-0.73	0.95
Total Liab	0.13	0.44	-0.5	-0.46	-0.44	0.78	0.04	0.57	0.22		-0.27	0.1	-0.03	0.13	0.34	0.32	0.23	0.09	0.74	-0.43	0.31	-0.48	0.3	0.24	-0.05	0.21
Short Long Term Debt	-0.16	0.14	0.12	0.23	-0.08	-0.36	-0.21	0.14	0.06	-0.27		-0.17	0.61	0.09	-0.27	0.18	-0.4	-0.16	-0.6	0.59	0.15	0.11	-0.13	-0.26	0.21	0.09
Total Current Assets	1.0	0.75	0.79	0.77	-0.78	0.63	0.97	0.53	0.83	0.1	-0.17		0.57	0.87	0.9	0.57	0.36	0.94	0.05	-0.39	0.75	-0.75	0.92	-0.52	-0.97	0.83
Short Term Debt	0.58	0.81	0.63	0.73	-0.79	0.29	0.47	0.69	0.8	-0.03	0.61	0.57		0.67	0.4	0.8	0.11	0.61	-0.48	0.17	0.78	-0.47	0.61	-0.59	-0.48	0.78
Common Stock	0.88	0.77	0.67	0.68	-0.79	0.54	0.79	0.57	0.76	0.13	0.09	0.87	0.67		0.75	0.58	0.38	0.86	-0.04	-0.25	0.79	-0.65	0.82	-0.44	-0.78	0.84
Property Plant Equipment	0.91	0.74	0.57	0.55	-0.73	0.77	0.87	0.49	0.77	0.34	-0.27	0.9	0.4	0.75		0.54	0.29	0.87	0.22	-0.56	0.75	-0.92	0.94	-0.19	-0.87	0.8
Net Receivables	0.6	0.92	0.43	0.53	-0.91	0.65	0.44	0.83	0.9	0.32	0.18	0.57	0.8	0.58	0.54		0.24	0.64	-0.24	-0.04	0.88	-0.65	0.71	-0.39	-0.46	0.84
Other Assets	0.38	0.35	0.14	0.1	-0.38	0.51	0.25	0.1	0.33	0.23	-0.4	0.36	0.11	0.38	0.29	0.24		0.5	0.1	-0.65	0.39	-0.25	0.46	0.04	-0.27	0.41
Other Current Assets	0.95	0.8	0.77	0.76	-0.81	0.63	0.86	0.53	0.89	0.09	-0.16	0.94	0.61	0.86	0.87	0.64	0.5		-0.06	-0.43	0.83	-0.74	0.94	-0.34	-0.86	0.92
Intangible Assets	0.04	-0.03	-0.49	-0.54	-0.01	0.46	0.1	0.18	-0.16	0.74	-0.6	0.05	-0.48	-0.04	0.22	-0.24	0.1	-0.06		-0.48	-0.19	-0.19	0.05	0.26	-0.1	-0.19
Short Long Term Debt Total	-0.39	-0.27	-0.06	0.02	0.24	-0.61	-0.39	-0.01	-0.23	-0.43	0.59	-0.39	0.17	-0.25	-0.56	-0.04	-0.65	-0.43	-0.48		-0.21	0.59	-0.56	-0.22	0.44	-0.25
Other Current Liab	0.78	0.94	0.53	0.59	-0.93	0.73	0.59	0.71	0.93	0.31	0.15	0.75	0.78	0.79	0.75	0.88	0.39	0.83	-0.19	-0.21		-0.78	0.86	-0.25	-0.6	0.98
Other Liab	-0.76	-0.82	-0.41	-0.44	0.77	-0.82	-0.7	-0.57	-0.78	-0.48	0.11	-0.75	-0.47	-0.65	-0.92	-0.65	-0.25	-0.74	-0.19	0.59	-0.78		-0.92	0.12	0.73	-0.77
Property Plant And Equipment Net	0.93	0.88	0.65	0.66	-0.87	0.78	0.85	0.6	0.9	0.3	-0.13	0.92	0.61	0.82	0.94	0.71	0.46	0.94	0.05	-0.56	0.86	-0.92		-0.31	-0.87	0.91
Current Deferred Revenue	-0.5	-0.37	-0.63	-0.67	0.42	-0.04	-0.59	-0.41	-0.43	0.24	-0.26	-0.52	-0.59	-0.44	-0.19	-0.39	0.04	-0.34	0.26	-0.22	-0.25	0.12	-0.31		0.58	-0.29
Net Debt	-0.95	-0.64	-0.79	-0.76	0.67	-0.55	-1.0	-0.44	-0.73	-0.05	0.21	-0.97	-0.48	-0.78	-0.87	-0.46	-0.27	-0.86	-0.1	0.44	-0.6	0.73	-0.87	0.58		-0.69
Non Current Assets Total	0.86	0.93	0.64	0.69	-0.92	0.69	0.69	0.68	0.95	0.21	0.09	0.83	0.78	0.84	0.8	0.84	0.41	0.92	-0.19	-0.25	0.98	-0.77	0.91	-0.29	-0.69

Click cells to compare fundamentals

PulmonxCorp Account Relationship Matchups

PulmonxCorp fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	53.5M	263.7M	235.2M	193.7M	179.0M	94.4M
Total Current Liabilities	14.2M	12.5M	17.6M	18.5M	23.2M	24.3M
Total Stockholder Equity	(187.4M)	226.1M	193.2M	154.0M	118.3M	124.2M
Net Tangible Assets	(190.2M)	223.4M	190.6M	151.7M	174.4M	183.1M
Retained Earnings	(210.5M)	(242.7M)	(291.4M)	(350.3M)	(411.2M)	(390.6M)
Accounts Payable	2.7M	1.5M	1.6M	1.8M	1.5M	1.2M
Cash	14.8M	231.6M	148.5M	101.7M	83.8M	58.6M
Long Term Debt	15.0M	17.4M	17.3M	17.2M	35.1M	36.8M
Inventory	5.6M	10.7M	16.3M	14.6M	16.7M	17.6M
Total Liab	240.9M	37.6M	41.9M	39.7M	60.6M	61.5M
Total Current Assets	41.1M	250.0M	208.0M	169.0M	150.3M	83.2M
Short Term Debt	446K	2.2M	2.3M	3.3M	5.2M	5.5M
Common Stock	19K	36K	37K	38K	39K	25.0K
Property Plant Equipment	7.5M	10.5M	12.9M	5.3M	6.1M	4.1M
Net Receivables	5.9M	4.2M	6.6M	8.7M	13.4M	14.1M
Other Assets	2.1M	536K	731K	5.8M	1.0	0.95
Other Current Assets	766K	3.2M	4.9M	4.3M	2.8M	2.0M
Intangible Assets	524K	400K	277K	154K	31K	29.5K
Short Long Term Debt Total	21.8M	27.2M	26.5M	24.4M	41.4M	32.1M
Other Current Liab	10.9M	8.7M	13.5M	13.3M	16.3M	12.6M
Other Liab	43K	62K	37K	94K	84.6K	58.1K
Property Plant And Equipment Net	7.5M	10.5M	12.9M	10.5M	7.4M	9.0M
Current Deferred Revenue	173K	71K	163K	120K	104K	102.7K
Net Debt	7.0M	(204.3M)	(122.0M)	(77.3M)	(42.4M)	(44.5M)
Non Current Assets Total	12.5M	13.7M	27.2M	24.7M	28.6M	20.2M
Non Currrent Assets Other	2.1M	536K	252K	5.4M	3.3M	2.2M
Cash And Short Term Investments	28.3M	231.6M	180.0M	141.1M	117.3M	128.8M
Common Stock Total Equity	19K	36K	37K	38K	43.7K	32.3K
Common Stock Shares Outstanding	35.4M	35.7M	36.1M	37.1M	38.0M	37.2M
Liabilities And Stockholders Equity	53.5M	263.7M	235.2M	193.7M	179.0M	172.3M
Non Current Liabilities Total	226.8M	25.0M	24.4M	21.2M	37.5M	67.9M
Capital Lease Obligations	6.8M	9.9M	9.0M	7.1M	4.2M	6.8M
Other Stockholder Equity	(183.6M)	467.1M	482.9M	502.7M	526.8M	333.1M
Net Invested Capital	(172.4M)	243.5M	210.7M	171.3M	155.6M	87.1M
Property Plant And Equipment Gross	7.5M	10.5M	4.8M	4.7M	12.3M	7.3M
Accumulated Other Comprehensive Income	1.4M	1.7M	1.7M	1.6M	2.6M	1.9M
Capital Stock	19K	36K	37K	38K	39K	34.1K
Net Working Capital	26.9M	237.5M	190.5M	150.5M	127.3M	134.9M

Currently Active Assets on Macroaxis

MSFT	Microsoft
GM	General Motors
CRM	Salesforce
MSFT	Microsoft
GOOG	Alphabet Inc Class C

When determining whether PulmonxCorp is a strong investment it is important to analyze PulmonxCorp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PulmonxCorp's future performance. For an informed investment choice regarding PulmonxCorp Stock, refer to the following important reports:

How To Invest In PulmonxCorp

Details

Is PulmonxCorp Stock a good investment?

Details

What is PulmonxCorp's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in PulmonxCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in PulmonxCorp Stock please use our How to Invest in PulmonxCorp guide.

You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for PulmonxCorp Stock analysis

When running PulmonxCorp's price analysis, check to measure PulmonxCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PulmonxCorp is operating at the current time. Most of PulmonxCorp's value examination focuses on studying past and present price action to predict the probability of PulmonxCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PulmonxCorp's price. Additionally, you may evaluate how the addition of PulmonxCorp to your portfolios can decrease your overall portfolio volatility.

	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Global Correlations Find global opportunities by holding instruments from different markets
	Content Syndication Quickly integrate customizable finance content to your own investment portal

Is PulmonxCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PulmonxCorp. If investors know PulmonxCorp will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PulmonxCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.54)

Revenue Per Share

1.909

Quarterly Revenue Growth

0.297

Return On Assets

(0.21)

Return On Equity

(0.46)

The market value of PulmonxCorp is measured differently than its book value, which is the value of PulmonxCorp that is recorded on the company's balance sheet. Investors also form their own opinion of PulmonxCorp's value that differs from its market value or its book value, called intrinsic value, which is PulmonxCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PulmonxCorp's market value can be influenced by many factors that don't directly affect PulmonxCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between PulmonxCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if PulmonxCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PulmonxCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PulmonxCorp Total Liab vs Capital Stock Analysis

Total Liab vs Capital Stock

Total Liab vs Capital Stock Correlation Analysis

Correlation Coefficient

Total Liab

Capital Stock

PulmonxCorp fundamental ratios Correlations

PulmonxCorp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PulmonxCorp fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for PulmonxCorp Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Non Current Assets Total	+ 0.98	Other Current Liab
Total Current Assets	+ 0.97	Cash
Cash	+ 0.96	Total Assets
Other Current Assets	+ 0.95	Total Assets

Net Debt	- 1.0	Cash
Retained Earnings	- 0.99	Total Current Liabilities
Net Debt	- 0.97	Total Current Assets
Inventory	- 0.95	Retained Earnings
Net Debt	- 0.95	Total Assets
Other Current Liab	- 0.93	Retained Earnings